Pierce County, WA's Series 2012 Sewer Revenue Bonds Rated 'AA' Aug 12

  • ID: 2201463
  • August 2012
  • Standard & Poors
1 of 3

SAN FRANCISCO (Standard & Poor's) Aug. 3, 2012-- Standard & Poor's Ratings Services assigned its 'AA' long-term rating to Pierce County, Wash.'s series 2012 sewer revenue bonds, issued for the county's sewer system. At the same time, Standard & Poor's affirmed its 'AA' underlying rating (SPUR) on the county's outstanding sewer revenue bonds. The outlook is stable. "The sewer system's financial performance has been strong, in our view though annual debt service will increase after this issue and a planned future issue, likely lowering debt service coverage going forward," said Standard & Poor's credit analyst Robert Hannay. The series 2012 bonds are being issued to provide $196 million in capital funding for the county's sewer system, including the system's wastewater...

Companies mentioned in this report are:
- Pierce Cnty

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Pierce Cnty

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.